Skip to main content

Find Clinical Trials

Home
Conditions
Systemic Vasculitis

Clinical trial condition

Systemic Vasculitis

Explore clinical trials studying Systemic Vasculitis. Study availability and eligibility vary by location and protocol.

183 public trials 63 recruiting studies

Refine in advanced search Browse all conditions

Systemic Vasculitis trial results

Recruiting

A Study of Anti-CD19/BCMA Universal CAR-T Cell Therapy RD06-05 in Patients With Autoimmune Diseases.

NCT07203404

Conditions: ANCA Associated Vasculitis, ANCA-Associated Glomerulonephritis, Anti-GBM Disease, +27 more
Locations: Bioheng Study site Shanghai, China

View Trial Details

Recruiting

CAR T-cell Therapy Targeting CD19 and BCMA in Patients With Relapse/Refractory Autoimmune Diseases

NCT06941129

Conditions: ANCA-Associated Vasculitis (AAV), Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis, Autoimmune Diseases, +21 more
Locations: Institute of Hematology & Blood Diseases Hospital Tianjin, China

View Trial Details

Recruiting

Clinical Assessment for Rheumatologic Disease - Research and Advancement in Safety and Efficacy

NCT07150000

Conditions: ANCA Associated Vasculitis (AAV), Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis, Arteritis, +55 more
Locations: University Hospital, Bonn Bonn, North Rhine-Westphalia, Germany

View Trial Details

Recruiting

Safety and Efficacy of Universal CD19-targeting CAR-γδT Cells in Refractory Autoimmune Diseases

NCT06828042

Conditions: ANCA Associated Vasculitis (AAV), Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis, Antiphospholipid Syndrome, +32 more
Locations: Peking University Third Hospital Beijing, China

View Trial Details

Recruiting

A Clinical Study of YTS109 Cell in R/R Autoimmune Diseases

NCT06978647

Conditions: Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis, Anti-neutrophil Cytoplasmic Antibody-associated Vasculitis, Antiphospholipid Syndrome, +29 more
Locations: The First Medical Center of Chinese PLA General Hospital Beijing, Beijing Municipality, China

View Trial Details

Recruiting

A Study of OL-108 in Relapsed/Refractory Autoimmune Diseases

NCT06980597

Conditions: ANCA Associated Vasculitis (AAV), Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis, Autoimmune Diseases, +19 more
Locations: Beijing Boren Hospital Beijing, China

Beijing GoBroad Hospital Beijing, China

View Trial Details

Recruiting

Avacopan vs Reduced-dose Glucocorticoids in ANCA-associated Vasculitis

NCT06611696

Conditions: ANCA Associated Vasculitis (AAV), Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis, Autoimmune Diseases, +18 more
Locations: Fujita Health University Hospital Toyoake, Aichi-ken, Japan

Asahi General Hospital Asahi, Chiba, Japan

Chiba Aoba Municipal Hospital Chiba, Japan

Chiba University Chiba, Japan

View all 22 locations

View Trial Details

Recruiting

Anti-CD19 CAR T-Cell Therapy in Refractory Systemic Autoimmune Diseases

NCT06685042

Conditions: ANCA Associated Vasculitis, Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis, Autoimmune Diseases, +20 more
Locations: Fondazione Policlinico Universitario A. Gemelli IRCCS Rome, Lazio, Italy

View Trial Details

Recruiting

AYLo - AutoimmunitY and Loss of y

NCT06696027

Conditions: ANCA Associated Vasculitis (AAV), Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis, Arteritis, +61 more
Locations: Department of Rheumatology Bonn, North Rhine-Westphalia, Germany

View Trial Details

Recruiting

BCMA-CD19 CAR-T Therapy for Refractory Autoimmune Diseases

NCT06794008

Conditions: ANCA-associated Vasculitis, Acquired Thrombotic Thrombocytopenic Purpura, Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis, +62 more
Locations: Department of Rheumatology and Immunology, Peking University People's Hospital Beijing, Beijing Municipality, China

View Trial Details